|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/54 | (2006.01) |
| C07K 16/289 | (2013.01) | ||
| A61K 47/60 | (2017.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 47/54 | (2017.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3737694 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19703451.5 |
| Date of filing the European patent application | 2019-01-11 | |
| (97) | Date of publication of the European application | 2020-11-18 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/013205 |
| Date | 2019-01-11 |
| (87) | Number | WO 2019/140196 |
| Date | 2019-07-18 |
| (30) | Number | Date | Country code |
| 201862616733 P | 2018-01-12 | US | |
| 201862770029 P | 2018-11-20 | US |
| (72) |
ALI, Khaled, M.K.Z. , US
AGRAWAL, Neeraj, Jagdish , US
KANNAN, Gunasekaran , US
FOLTZ, Ian , US
WANG, Zhulun , US
BATES, Darren , US
MOCK, Marissa , US
TAKENAKA, Shunsuke , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | ANTI-PD-1 ANTIBODIES AND METHODS OF TREATMENT |
| ANTI-PD-1 ANTIBODIES AND METHODS OF TREATMENT |